Epoch Biodesign raises €10.3 million to use AI and enzymes to recycle plastic and textile waste at commercial scale
Source ↗
👁 16
💬 0
Epoch Biodesign, a London-based BioTech startup specialising in enzymatic recycling technology, has closed a €10.3 million ($12 million) financing round to accelerate the commercialisation of its recycled nylon 6,6.
The investment includes participation from Lululemon, KOMPAS VC, Happiness Capital, Extantia, Leitmotif, and others. Last year, the company raised €17 million in Series A capital in an oversubscribed round led by Extantia Capital. With this latest funding, Epoch’s total capital rais
The investment includes participation from Lululemon, KOMPAS VC, Happiness Capital, Extantia, Leitmotif, and others. Last year, the company raised €17 million in Series A capital in an oversubscribed round led by Extantia Capital. With this latest funding, Epoch’s total capital rais
Comments (0)